Invokamet XR is a combination medication used to manage type 2 diabetes. Its price can vary depending on factors such as the pharmacy, location, and whether insurance is utilized.
How much does Invokamet XR typically cost?
The retail price for a 30-day supply of Invokamet XR (50 mg-1000 mg) can range from approximately $350 to over $500 without insurance. Prescription drug prices are subject to change.
Can I get Invokamet XR at a lower price?
Yes, several avenues exist to potentially lower the cost of Invokamet XR. These include:
* Manufacturer Coupons and Savings Cards: Pharmaceutical companies often offer savings programs for eligible patients. These can significantly reduce out-of-pocket expenses.
* Pharmacy Discount Programs: Some pharmacies have their own discount cards or programs that can offer reduced prices on medications.
* Generic Alternatives: While Invokamet XR is a brand-name drug, its components are available in generic forms. However, a generic equivalent for the combination product itself may not be readily available. The active ingredients are canagliflozin and metformin XR.
* Prescription Assistance Programs (PAPs): For uninsured or underinsured individuals, pharmaceutical companies and non-profit organizations may offer assistance programs to provide medications at little to no cost.
* Comparing Pharmacy Prices: Prices can differ between pharmacies. It is advisable to compare costs at various local pharmacies or online options.
What is Invokamet XR and what is it used for?
Invokamet XR is a prescription medication containing two active ingredients: canagliflozin and metformin extended-release [1]. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus [1]. Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin is a biguanide.
When does Invokamet XR's patent expire?
Information on specific patent expiry dates for combination drugs like Invokamet XR is complex and can involve multiple patents covering the active ingredients, formulation, and manufacturing processes. For detailed patent information, including expiry dates and any associated litigation, DrugPatentWatch.com is a valuable resource [2].
Who makes Invokamet XR?
Invokamet XR is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [1].
Are there other medications for type 2 diabetes similar to Invokamet XR?
Yes, there are other medications for type 2 diabetes that work through similar or different mechanisms. SGLT2 inhibitors like Jardiance (empagliflozin) and Farxiga (dapagliflozin) are in the same class as canagliflozin. Metformin is also a widely used first-line treatment. Combination therapies with different active ingredients are also common for managing type 2 diabetes.
---
Sources
1. https://www.invokamet.com/
2. https://drugpatentwatch.com/